Literature DB >> 16358425

Ehrlichia under our noses and no one notices.

D H Walker1.   

Abstract

Ehrlichia chaffeensis, an obligately intracellular bacterium, resides within a cytoplasmic vacuole in macrophages, establishes persistent infection in natural hosts such as white-tailed deer and canids, and is transmitted transstadially and during feeding by ticks, particularly Amblyomma americanum. Ehrlichial cell walls contain glycoproteins and a family of divergent 28 kDa proteins, but no peptidoglycan or lipopolysaccharide. The dense-cored ultrastructural form preferentially expresses certain glycoproteins, including a multiple repeat unit-containing adhesin. Ehrlichiae attach to L-selectin and E-selectin, inhibit phagolysosomal fusion, apoptosis, and JAK/STAT activation, and downregulate IL-12, IL-15, IL-18, TLR2 and 3, and CD14. Mouse models implicate overproduction of TNF-alpha by antigen-specific CD8 T lymphocytes in pathogenesis and strong type 1 CD4 and CD8 T lymphocyte responses, synergistic activities of IFN-gamma and TNF-alpha, and IgG2a antibodies in immunity. Human monocytotropic ehrlichiosis (HME) manifests as a flu-like illness that progresses in severity to resemble toxic shock-like syndrome, with meningoencephalitis or adult respiratory distress syndrome in some patients, and requires hospitalization in half. In immunocompromised patients, HME acts as an overwhelming opportunistic infection. In one family physician's practice, active surveillance for three years revealed an incidence of 1000 cases per million population. Diagnosis employs serology or polymerase chain reaction, which are not utilized sufficiently to establish the true impact of this emerging virus-like illness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16358425     DOI: 10.1007/3-211-29981-5_12

Source DB:  PubMed          Journal:  Arch Virol Suppl        ISSN: 0939-1983


  6 in total

1.  Cutaneous Plasmacytosis Associated with Ehrlichiosis in an African-American Patient.

Authors:  Luke Maxfield; Jarett Casale; Muneeb Shah; Mikél E Muse; Dana Baigrie
Journal:  J Clin Aesthet Dermatol       Date:  2021-03-01

2.  Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge.

Authors:  Nagaraja R Thirumalapura; Heather L Stevenson; David H Walker; Nahed Ismail
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

3.  Antigenic protein modifications in Ehrlichia.

Authors:  S Thomas; N Thirumalapura; E C Crossley; N Ismail; D H Walker
Journal:  Parasite Immunol       Date:  2009-06       Impact factor: 2.280

4.  Dermatologic changes induced by repeated Ixodes scapularis bites and implications for prevention of tick-borne infection.

Authors:  Peter J Krause; Jane M Grant-Kels; Steven R Tahan; Kenneth R Dardick; Francisco Alarcon-Chaidez; Keith Bouchard; Christine Visini; Cindy Deriso; Ivo M Foppa; Stephen Wikel
Journal:  Vector Borne Zoonotic Dis       Date:  2009-12       Impact factor: 2.133

5.  Structure-based vaccines provide protection in a mouse model of ehrlichiosis.

Authors:  Sunil Thomas; Nagaraja R Thirumalapura; Patricia A Crocquet-Valdes; Bruce A Luxon; David H Walker
Journal:  PLoS One       Date:  2011-11-17       Impact factor: 3.240

6.  Ehrlichia chaffeensis EplA Interaction With Host Cell Protein Disulfide Isomerase Promotes Infection.

Authors:  Ryan S Green; Jerilyn R Izac; Waheeda A Naimi; Nathaniel O'Bier; Edward B Breitschwerdt; Richard T Marconi; Jason A Carlyon
Journal:  Front Cell Infect Microbiol       Date:  2020-09-23       Impact factor: 6.073

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.